NRP1 and melanoma: On the one hand, an increase in the NRP-1 phenotype induces the production of IFN-γ in the tumor, which increases the vulnerability of Tregs, weakens tumor immunosuppression, and enhances antitumor immunity, which is related to the prognosis of melanoma (173) and head and neck squamous cell carcinoma (174).